Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022

Upgrades

Craig-Hallum upgraded the previous rating for CalAmp Corp (NASDAQ:CAMP) from Hold to Buy. In the first quarter, CalAmp showed an EPS of $0.10, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.62 and a 52-week-low of $3.90. CalAmp closed at $5.80 at the end of the last trading period.
For Diffusion Pharmaceuticals Inc (NASDAQ:DFFN), HC Wainwright & Co. upgraded the previous rating of Neutral to Buy. For the second quarter, Diffusion Pharmaceuticals had an EPS of $2.06, compared to year-ago quarter EPS of $2.00. The current stock performance of Diffusion Pharmaceuticals shows a 52-week-high of $9.35 and a 52-week-low of $0.17. Moreover, at the end of the last trading period, the closing price was at $7.00.
Mizuho upgraded the previous rating for SITE Centers Corp (NYSE:SITC) from Neutral to Buy. SITE Centers earned $0.31 in the second quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.22 and a 52-week-low of $12.39. SITE Centers closed at $15.16 at the end of the last trading period.
For Seagen Inc (NASDAQ:SGEN), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Seagen earned $0.73 in the second quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $183.00 and a 52-week-low of $105.43. At the end of the last trading period, Seagen closed at $168.53.

See all analyst ratings upgrades.

Downgrades

See all analyst ratings downgrades.

Initiations

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Upgrades

Craig-Hallum upgraded the previous rating for CalAmp Corp (NASDAQ:CAMP) from Hold to Buy. In the first quarter, CalAmp showed an EPS of $0.10, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.62 and a 52-week-low of $3.90. CalAmp closed at $5.80 at the end of the last trading period.
For Diffusion Pharmaceuticals Inc (NASDAQ:DFFN), HC Wainwright & Co. upgraded the previous rating of Neutral to Buy. For the second quarter, Diffusion Pharmaceuticals had an EPS of $2.06, compared to year-ago quarter EPS of $2.00. The current stock performance of Diffusion Pharmaceuticals shows a 52-week-high of $9.35 and a 52-week-low of $0.17. Moreover, at the end of the last trading period, the closing price was at $7.00.
Mizuho upgraded the previous rating for SITE Centers Corp (NYSE:SITC) from Neutral to Buy. SITE Centers earned $0.31 in the second quarter, compared to $0.31 in the year-ago quarter. At the moment, the stock has a 52-week-high of $17.22 and a 52-week-low of $12.39. SITE Centers closed at $15.16 at the end of the last trading period.
For Seagen Inc (NASDAQ:SGEN), RBC Capital upgraded the previous rating of Sector Perform to Outperform. Seagen earned $0.73 in the second quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $183.00 and a 52-week-low of $105.43. At the end of the last trading period, Seagen closed at $168.53.

See all analyst ratings upgrades.

Downgrades

According to CLSA, the prior rating for Coupang Inc (NYSE:CPNG) was changed from Outperform to Sell. For the second quarter, Coupang had an EPS of $0.04, compared to year-ago quarter EPS of $0.30. At the moment, the stock has a 52-week-high of $29.65 and a 52-week-low of $8.98. Coupang closed at $18.10 at the end of the last trading period.
For Aerovate Therapeutics Inc (NASDAQ:AVTE), BTIG downgraded the previous rating of Buy to Neutral. Aerovate Therapeutics earned $0.49 in the second quarter, compared to $23.80 in the year-ago quarter. The current stock performance of Aerovate Therapeutics shows a 52-week-high of $27.83 and a 52-week-low of $7.74. Moreover, at the end of the last trading period, the closing price was at $25.54.
For Clean Energy Fuels Corp (NASDAQ:CLNE), Raymond James downgraded the previous rating of Outperform to Market Perform. Clean Energy Fuels earned $0.00 in the second quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $8.65 and a 52-week-low of $4.02. At the end of the last trading period, Clean Energy Fuels closed at $7.99.
For EVO Payments Inc (NASDAQ:EVOP), BTIG downgraded the previous rating of Buy to Neutral. For the second quarter, EVO Payments had an EPS of $0.30, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $33.86 and a 52-week-low of $21.01. At the end of the last trading period, EVO Payments closed at $33.53.
Raymond James downgraded the previous rating for TPI Composites Inc (NASDAQ:TPIC) from Strong Buy to Outperform. For the second quarter, TPI Composites had an EPS of $0.48, compared to year-ago quarter EPS of $1.08. The stock has a 52-week-high of $25.05 and a 52-week-low of $9.23. At the end of the last trading period, TPI Composites closed at $22.40.
According to Raymond James, the prior rating for Public Storage (NYSE:PSA) was changed from Strong Buy to Outperform. Public Storage earned $3.99 in the second quarter, compared to $3.15 in the year-ago quarter. The stock has a 52-week-high of $421.76 and a 52-week-low of $293.39. At the end of the last trading period, Public Storage closed at $355.34.
For Avalara Inc (NYSE:AVLR), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Avalara had an EPS of $0.02, compared to year-ago quarter EPS of $0.02. The stock has a 52-week-high of $129.34 and a 52-week-low of $66.39. At the end of the last trading period, Avalara closed at $92.06.
Morgan Stanley downgraded the previous rating for Equifax Inc (NYSE:EFX) from Overweight to Equal-Weight. In the second quarter, Equifax showed an EPS of $2.09, compared to $1.98 from the year-ago quarter. The stock has a 52-week-high of $294.93 and a 52-week-low of $169.25. At the end of the last trading period, Equifax closed at $220.24.
According to JP Morgan, the prior rating for Rackspace Technology Inc (NASDAQ:RXT) was changed from Neutral to Underweight. For the second quarter, Rackspace Tech had an EPS of $0.17, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $13.98 and a 52-week-low of $5.40. At the end of the last trading period, Rackspace Tech closed at $5.82.
JP Morgan downgraded the previous rating for Trinet Group Inc (NYSE:TNET) from Neutral to Underweight. Trinet Group earned $1.72 in the second quarter, compared to $1.56 in the year-ago quarter. The current stock performance of Trinet Group shows a 52-week-high of $103.36 and a 52-week-low of $69.16. Moreover, at the end of the last trading period, the closing price was at $91.97.
Oppenheimer downgraded the previous rating for ChromaDex Corp (NASDAQ:CDXC) from Outperform to Perform. For the second quarter, ChromaDex had an EPS of $0.09, compared to year-ago quarter EPS of $0.08. At the moment, the stock has a 52-week-high of $4.03 and a 52-week-low of $1.51. ChromaDex closed at $1.76 at the end of the last trading period.
For Maxeon Solar Technologies Ltd (NASDAQ:MAXN), Raymond James downgraded the previous rating of Outperform to Market Perform. For the first quarter, Maxeon Solar Technologies had an EPS of $1.45, compared to year-ago quarter EPS of $1.14. The current stock performance of Maxeon Solar Technologies shows a 52-week-high of $23.11 and a 52-week-low of $7.48. Moreover, at the end of the last trading period, the closing price was at $22.14.
For Sema4 Holdings Corp (NASDAQ:SMFR), Jefferies downgraded the previous rating of Buy to Hold. In the second quarter, Sema4 Holdings showed an EPS of $0.22, compared to $0.00 from the year-ago quarter. The stock has a 52-week-high of $4.67 and a 52-week-low of $1.11. At the end of the last trading period, Sema4 Holdings closed at $2.40.
B. Riley Securities downgraded the previous rating for Bed Bath & Beyond Inc (NASDAQ:BBBY) from Neutral to Sell. In the first quarter, Bed Bath & Beyond showed an EPS of $2.83, compared to $0.05 from the year-ago quarter. The current stock performance of Bed Bath & Beyond shows a 52-week-high of $30.06 and a 52-week-low of $4.38. Moreover, at the end of the last trading period, the closing price was at $16.00.
For Zoom Video Communications Inc (NASDAQ:ZM), Citigroup downgraded the previous rating of Neutral to Sell. Zoom Video Comms earned $1.03 in the first quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $184.91 and a 52-week-low of $79.03. Zoom Video Comms closed at $113.23 at the end of the last trading period.
For Snowflake Inc (NYSE:SNOW), UBS downgraded the previous rating of Buy to Neutral. For the first quarter, Snowflake had an EPS of $0.08, compared to year-ago quarter EPS of $0.12. The stock has a 52-week-high of $344.00 and a 52-week-low of $110.27. At the end of the last trading period, Snowflake closed at $170.44.
BMO Capital downgraded the previous rating for Park Hotels & Resorts Inc (NYSE:PK) from Outperform to Market Perform. Park Hotels & Resorts earned $0.61 in the second quarter, compared to $0.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $20.57 and a 52-week-low of $12.90. Park Hotels & Resorts closed at $15.90 at the end of the last trading period.
According to Cowen & Co., the prior rating for Aptinyx Inc (NASDAQ:APTX) was changed from Outperform to Market Perform. For the second quarter, Aptinyx had an EPS of $0.26, compared to year-ago quarter EPS of $0.29. At the moment, the stock has a 52-week-high of $3.76 and a 52-week-low of $0.36. Aptinyx closed at $0.38 at the end of the last trading period.
According to JP Morgan, the prior rating for Elanco Animal Health Inc (NYSE:ELAN) was changed from Overweight to Neutral. In the second quarter, Elanco Animal Health showed an EPS of $0.36, compared to $0.28 from the year-ago quarter. The stock has a 52-week-high of $29.66 and a 52-week-low of $18.64. At the end of the last trading period, Elanco Animal Health closed at $19.36.
According to JP Morgan, the prior rating for Rapid Micro Biosystems Inc (NASDAQ:RPID) was changed from Overweight to Neutral. In the second quarter, Rapid Micro Biosystems showed an EPS of $0.31, compared to $20.01 from the year-ago quarter. The stock has a 52-week-high of $11.34 and a 52-week-low of $2.49. At the end of the last trading period, Rapid Micro Biosystems closed at $3.83.

See all analyst ratings downgrades.

Initiations

Guggenheim initiated coverage on POINT Biopharma Global Inc (NASDAQ:PNT) with a Buy rating. The price target for POINT Biopharma Global is set to $20.00. POINT Biopharma Global earned $0.27 in the second quarter, compared to $0.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.63 and a 52-week-low of $5.22. POINT Biopharma Global closed at $8.67 at the end of the last trading period.
Wolfe Research initiated coverage on Matson Inc (NYSE:MATX) with an Underperform rating. The price target for Matson is set to $80.00. In the second quarter, Matson showed an EPS of $9.49, compared to $3.71 from the year-ago quarter. The current stock performance of Matson shows a 52-week-high of $125.34 and a 52-week-low of $68.36. Moreover, at the end of the last trading period, the closing price was at $85.90.
Piper Sandler initiated coverage on Alkermes PLC (NASDAQ:ALKS) with a Neutral rating. The price target for Alkermes is set to $26.00. Alkermes earned $0.06 in the second quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Alkermes shows a 52-week-high of $32.79 and a 52-week-low of $22.72. Moreover, at the end of the last trading period, the closing price was at $26.60.
With a Buy rating, HC Wainwright & Co. initiated coverage on GH Research PLC (NASDAQ:GHRS). The price target seems to have been set at $45.00 for GH Research. For the first quarter, GH Research had an EPS of $0.11, compared to year-ago quarter EPS of $0.04. The current stock performance of GH Research shows a 52-week-high of $24.25 and a 52-week-low of $8.72. Moreover, at the end of the last trading period, the closing price was at $13.34.
With a Neutral rating, JP Morgan initiated coverage on EQRx Inc (NASDAQ:EQRX). The price target seems to have been set at $5.50 for EQRx. EQRx earned $0.17 in the second quarter, compared to $0.11 in the year-ago quarter. The current stock performance of EQRx shows a 52-week-high of $7.79 and a 52-week-low of $2.63. Moreover, at the end of the last trading period, the closing price was at $4.98.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022

ArticleFeaturedTickersList12345!!!

Upgrades

Downgrades

Initiations

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022

ArticleFeaturedTickersList12345!!!

Upgrades

Downgrades

Initiations

Comments

Comments